
News|Articles|February 2, 2005
- Pharmaceutical Technology-02-02-2005
- Volume 29
- Issue 2
Using Extrusion-Spheronization to Develop Controlled-Release Formulations of Azithromycin
Extrusion-spheronization and pellet compression are effective means of developing first-order kinetic, controlled-release drug delivery systems of azithromycin (AZI). The authors prepared, evaluated, and optimized AZI formulations and assessed the stability of the selected formulation under accelerated storage conditions.
Advertisement
Articles in this issue
over 21 years ago
Correcting the Courseover 21 years ago
February 2005over 21 years ago
Good Work and True: USP Prepares for Convention 2005over 21 years ago
Contract Manufacturers Getting Squeezedover 21 years ago
In the Spotlight-February 2005over 21 years ago
Emerging Analytical Technology: Moving from the Lab to the Lineover 21 years ago
Drug Safety Fears May Limit Reimporting and Shape R&Dover 21 years ago
In Defense of USP Singlet TestingAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma Fundamentals: Hold Times in Biopharmaceuticals
2
FDA Updates Master Protocol: What Developers Need to Know
3
FDA Approves Pfizer’s Breast Cancer Treatment
4
Merck KGaA Launches Saturnus Bio; Announces Awards
5




